Cancer Therapy BNCT System

We exclusively represent the NeuCure BNCT system by Sumitomo Heavy Industries for the Canadian and European markets, offering full export support and clinical integration.

NeuCure™ BNCT System by Sumitomo Heavy Industries

NeuCure is Sumitomo Heavy Industries’ state-of-the-art BNCT (Boron Neutron Capture Therapy) system, designed to treat deep-seated or non-operable tumors with precision neutron beams.
Marsole is the exclusive export partner for NeuCure in Canada and the EU, supporting hospitals through clinical onboarding, licensing, and investor relations.

Key Highlights

• Developed by Japan’s leading heavy industry firm, Sumitomo

• Suitable for head & neck cancers, melanoma, and glioblastoma

• Minimally invasive, outpatient-based therapy

Global Partnership Invitation

Marsole is actively seeking regional distributors, hospital groups, and government procurement partners interested in Sumitomo’s BNCT System.